Endoscope Reprocessing Market Size, Share and Growth Outlook, 2026

Endoscope Reprocessing Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Endoscope Reprocessing Market size is forecast to increase from $3.17 Billion in 2026 to $6.46 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034.

The Endoscope Reprocessing market report provides detailed analysis and outlook of Endoscope Reprocessing segments including By Product Type (Automated Endoscope Reprocessors, High-Level Disinfectants, Detergents, Enzymatic Cleaners, & Reprocessing Wipes, Endoscope Drying, Storage, & Transport Systems, Manual Cleaning Stations & Flushing Systems, Tracking, Traceability, & Workflow Digital Solutions), By Endoscope Modality (Flexible Endoscopes, Rigid Endoscopes, Robot-Assisted Endoscopes), By Application (Gastrointestinal, Pulmonology & Bronchoscopy, Urology & Gynecology, Otolaryngology, Cardiology ), By End-User (Hospitals & Central Sterile Supply Departments, Ambulatory Surgical Centers, Specialized Outpatient Clinics & Diagnostic Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Endoscope Reprocessing Industry Overview

Increasing Focus on Automated Reprocessing and Sterile Workflow Management

The endoscope reprocessing industry is experiencing sustained technological advancement as healthcare organizations strengthen infection control protocols and seek more efficient instrument reprocessing solutions. Growing procedure volumes, heightened regulatory scrutiny, and rising awareness of endoscope-related contamination risks are driving demand for automated endoscope reprocessors, connected washer-disinfector systems, and integrated sterilization workflows. Manufacturers are focusing on automation, digital monitoring, and capacity expansion to support the evolving needs of hospitals and central sterile processing departments.

Strategic Integration Expanding Comprehensive Reprocessing Solutions

Industry consolidation is enhancing the availability of end-to-end reprocessing solutions. HOYA Corporation completed the operational integration of Wassenburg Medical B.V., combining HOYA’s optical and diagnostic expertise with Wassenburg’s automated endoscope reprocessing technologies. This strategic alignment enables healthcare facilities to access integrated solutions that support the entire workflow, from diagnostic imaging procedures through validated high-level disinfection and instrument reprocessing. The development highlights growing demand for comprehensive infection prevention ecosystems that streamline workflow management while maintaining strict hygiene standards.

IoT-Enabled Reprocessors Supporting Regulatory Compliance

Digital connectivity is becoming a key differentiator within the endoscope reprocessing market. Getinge AB introduced enhanced connectivity modules across its automated endoscope washer-disinfector portfolio, incorporating integrated IoT sensors capable of monitoring fluid dynamics, detergent concentrations, and water temperature parameters in real time. These operational metrics are automatically recorded and transmitted across enterprise networks, allowing sterile processing departments to validate performance and demonstrate compliance with ISO 15883 requirements. The adoption of connected reprocessing systems is improving transparency, process control, and quality assurance across healthcare facilities.

Expanded Manufacturing Capacity Addressing High-Volume Reprocessing Demand

Manufacturers are increasing production capabilities to meet growing global demand for automated reprocessing equipment. Steelco S.p.A., part of the Miele Group, expanded manufacturing capacity for its automated endoscope reprocessor portfolio. The production enhancement focuses on standalone double-basin systems featuring decoupled dual-chamber processing pathways. This configuration allows healthcare professionals to simultaneously clean and disinfect flexible gastroscopes and colonoscopes while preventing cross-contamination between devices. Increased deployment of high-throughput automated reprocessors is supporting healthcare facilities seeking greater processing efficiency, improved instrument availability, and enhanced infection control performance.

Endoscope Reprocessing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Endoscope Reprocessing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Olympus Corporation, STERIS plc, Getinge AB, Advanced Sterilization Products (ASP), Ecolab Inc., Fujifilm Holdings, Pentax Medical (HOYA), Karl Storz SE & Co. KG, Boston Scientific Corporation, Stryker Corporation. The Endoscope Reprocessing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Endoscope Reprocessing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Endoscope Reprocessing Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Endoscope Reprocessing companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Endoscope Reprocessing markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Endoscope Reprocessing Market Competitive Benchmarking and Company Analysis

Leading companies in Endoscope Reprocessing industry include- Olympus Corporation, STERIS plc, Getinge AB, Advanced Sterilization Products (ASP), Ecolab Inc., Fujifilm Holdings, Pentax Medical (HOYA), Karl Storz SE & Co. KG, Boston Scientific Corporation, Stryker Corporation. The Endoscope Reprocessing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Endoscope Reprocessing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Endoscope Reprocessing market remains one of the strongest-performing segments in the country.
The US Endoscope Reprocessing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Endoscope Reprocessing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Endoscope Reprocessing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Endoscope Reprocessing markets

Canada's strong Endoscope Reprocessing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Endoscope Reprocessing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Endoscope Reprocessing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Endoscope Reprocessing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Endoscope Reprocessing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Endoscope Reprocessing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Endoscope Reprocessing market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Endoscope Reprocessing sales through 2034

France Endoscope Reprocessing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Endoscope Reprocessing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Endoscope Reprocessing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Endoscope Reprocessing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Endoscope Reprocessing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Endoscope Reprocessing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Endoscope Reprocessing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Endoscope Reprocessing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Endoscope Reprocessing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Endoscope Reprocessing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Endoscope Reprocessing Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Endoscope Reprocessing Market Segmentation

By Product Type
Automated Endoscope Reprocessors
High-Level Disinfectants
Detergents, Enzymatic Cleaners, & Reprocessing Wipes
Endoscope Drying, Storage, & Transport Systems
Manual Cleaning Stations & Flushing Systems
Tracking, Traceability, & Workflow Digital Solutions
By Endoscope Modality
Flexible Endoscopes
Rigid Endoscopes
Robot-Assisted Endoscopes
By Application
Gastrointestinal
Pulmonology & Bronchoscopy
Urology & Gynecology
Otolaryngology
Cardiology
By End-User
Hospitals & Central Sterile Supply Departments
Ambulatory Surgical Centers
Specialized Outpatient Clinics & Diagnostic Centers

Top Companies in Endoscope Reprocessing Industry

Olympus Corporation
STERIS plc
Getinge AB
Advanced Sterilization Products (ASP)
Ecolab Inc.
Fujifilm Holdings
Pentax Medical (HOYA)
Karl Storz SE & Co. KG
Boston Scientific Corporation
Stryker Corporation

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025